NCT00001302View on ClinicalTrials.gov

A Phase I Study of Infusional Chemotherapy With the P-Glycoprotein Antagonist PSC 833

PHASE1CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

September 30, 1992

Study Completion Date

June 30, 2002

Conditions
Breast CancerKidney NeoplasmLymphomaNeoplasm MetastasisOvarian Cancer
Interventions
DRUG

PSC 833

Trial Locations (1)

20892

National Cancer Institute (NCI), Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00001302 - A Phase I Study of Infusional Chemotherapy With the P-Glycoprotein Antagonist PSC 833 | Biotech Hunter | Biotech Hunter